Dormant Blood Stem-Cell Discovery Opens a New Research Question, Not a Human Treatment

Heidelberg, Germany, 3 November 2026 – Researchers at the German Cancer Research Center and the Heidelberg Institute for Stem Cell Technology and Experimental Medicine have identified an unusually dormant population of blood stem cells in mice. The study, published on 28 October, found that 10–15% of these cells retained a dormancy marker after more than 200 days, compared with about 2% of conventional blood stem cells.

The finding adds to scientific understanding of how blood-forming cells preserve their capacity to renew themselves. For Asian biotechnology businesses and investors, however, its significance remains at the research stage: a comparable long-lived population has not been established in humans, and the work does not demonstrate a new treatment, a clinical success rate or a commercially available therapy.